FormFactor director plans $201,810 stock sale
A FormFactor director filed a Rule 144 notice to sell 2,100 restricted shares of common stock via broker Morgan Stanley Smith Barney.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
FORMFACTOR, INC. (FORM) received a Rule 144 notice that director Kelley Lynne Steven-Waiss plans to sell restricted common stock. The filing covers a proposed sale of 2,100 shares of common stock, acquired from the issuer on May 16, 2026, to be sold through Morgan Stanley Smith Barney LLC.
The shares are listed on NASDAQ, and the proposed transaction date is September 3, 2026. The filing states an aggregate market value for the covered securities of $201,810.21, providing investors with visibility into a potential insider sale, though the company itself is not a party to the transaction.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock financial
aggregate market value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing disclose for FORM (FormFactor, Inc.)?
AI-generated analysis. How Rhea-AI works. Not financial advice.